GEOMATCH
DEAD

Serial Number

98039630

Owner

Adaptive Phage Therapeutics, Inc.

Attorney

Leesa N. Weiss

Filing Date

Jun 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GEOMATCH Trademark

Serial Number: 98039630

GEOMATCH is a trademark filed by Adaptive Phage Therapeutics, Inc. on June 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Adaptive Phage Therapeutics, Inc. (25 trademarks)

Gaithersburg, MD 20878

Entity Type: 03

Trademark Details

Filing Date

June 13, 2023

Registration Date

Not Registered

Published for Opposition

April 9, 2024

Goods & Services

Human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; none of the aforementioned goods used in manufacturing

Medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine

Research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals; clinical and medical laboratory testing services in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 6, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 6, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2024 CNSA
ASSIGNED TO EXAMINER
Mar 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2023 NWOS
NEW APPLICATION ENTERED
Jun 16, 2023 NWAP